The Chinese Academy of Sciences (CAS) and the Institut Pasteur, two key institutions of Sino-French Cooperation on Emerging Infectious Diseases since 2003, reached the consensus to make sustained common efforts to defeat the COVID-19 pandemic at a video-conference on May 15.
"Scientific international cooperation has never been more important than it is today", said Prof. ZHANG Yaping, Vice-President of the Chinese Academy of Sciences (CAS), at a video-conference specially launched for COVID-19 scientific response between CAS and Mérieux Foundation on 7 may, 2020.
Recently, the Remote Sensing of Urban Green Space was published by Science Press as China's first monograph that comprehensively studies urban vegetation from the perspective of remote sensing. Authored by Prof. MENG Qingyan from the Aerospace Information Research Institute, the book is a result of decade efforts of MENG and his team in the field of urban green space remote sensing since 2010.
The successful CAS-JIC Centre of Excellence for Plant and Microbial Science (CEPAMS) was boosted today by the signing of a new five-year agreement between the three partner institutes in Beijing, Shanghai and Norwich. The next five years will see an expansion of the CEPAMS laboratories in China and a renewed emphasis on harnessing the strengths of Chinese and UK science for global good.
Requested by UNESCO World Heritage Center (WHC), the International Centre on Space Technologies for Natural and Cultural Heritage (HIST) under the auspices of UNESCO conducted an emergency monitoring and assessment of potential impact of Super Tropical Cyclone Harold on East Rennell, a World Natural Heritage site in Rennell Bellona Province, one of four affected provinces of the Solomon Islands which are among four cyclone-stricken countries in early April, 2020. The assessment report was delivered to UNESCO WHC on April, 24.
Oligomannate (compound code GV-971), a drug developed in China to improve cognitive function for those with mild to moderate Alzheimer's disease, got formal approval on Apr. 8 from the US Food and Drug Administration (FDA) for its international multi-center Phase III clinical study in the U.S..
52 Sanlihe Rd., Beijing,
Copyright © 2002 - Chinese Academy of Sciences